Abstract: The invention relates to enamine resins which are the reaction products of a) an acetoacetylated resin, and a C1-C20 alkyl amine or a mixture of C1-C20 alkyl amines. The acetoacetylated resin is the reaction product of a polyol having 4 or more hydroxyl groups; and at least one acetoacetate. The invention also relates to an acetoacetylated resin which is the reaction product of a polyol having 4 or more hydroxyl groups and at least one acetoacetate, where a portion of the hydroxyl groups of the polyol are replaced by acetoacetate groups and the remaining hydroxyl groups are replaced by a saturated monofunctional carboxylic acid ester, unsaturated monofunctional carboxylic acid ester, or a mixture thereof; as well as to enamine resins prepared from these acetoacetylated resins. The invention also relates to curable coating compositions containing such resins or a mixture of those resins, at least one metallic drier compound; and optionally one or more solvents.

Abstract: A laterally-stretched netting comprising a patterned abrasive layer on a first major surface thereof, and methods of making.

Abstract: The invention provides structural biocomposites comprising cellulose-based bast natural fibers, glass fibers, or mixtures thereof, and polyurethanes. The polyurethanes are synthesized from the reaction of polyfunctional bio-based polyols with polyisocyanates. The resultant polyurethanes have higher moduli, hardness, and Tg compared to other bio- and petroleum-based polyols. Methods of making the structural biocomposites are also disclosed.

Abstract: The present disclosure describes novel PKC-? activators chosen from halogenated esters of unsaturated fatty acids derivatives thereof, including halogenated esters of both polyunsaturated and monunsaturated fatty acids and derivatives thereof. The disclosure further relates to compositions, kits, and methods for treatment using the halogenated esters.

Abstract: The present invention relates to methods of activate an isoform of protein kinase C (PKC) for the treatment of neurological diseases including Alzheimer's disease and stroke using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids. The present invention also relates to methods of reducing neurodegeneration using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids.

Abstract: The present disclosure relates to esters of 8-[2-(2-pentyl-cyclopropylmethyl)cyclopropyl]-octanoic acid (“DCPLA”). The disclosure further relates to compositions, kits, and methods for treatment using the esters.

Abstract: The present invention relates to methods of activate an isoform of protein kinase C (PKC) for the treatment of neurological diseases including Alzheimer's disease and stroke using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids. The present invention also relates to methods of reducing neurodegeneration using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids.

Abstract: The present disclosure relates to esters of 8-[2-(2-pentyl-cyclopropylmethyl)cyclopropyl]-octanoic acid (“DCPLA”). The disclosure further relates to compositions, kits, and methods for treatment using the esters.

Abstract: The present disclosure relates to PKC activators and combinations thereof. The disclosure further relates to compositions, kits, uses, and methods thereof.

Abstract: Alkyd resin compositions which comprise the monomer-grafting polymerization of a) an alkyd, which is an ester of a polyol having 4 or more hydroxyl groups and an unsaturated fatty acid, and b) an unsaturated monomer having a carbon-carbon double bond are disclosed. The alkyd may be a partially esterified polyol. Coating compositions of containing the alkyd resin compositions of the invention are also disclosed.

Abstract: The invention relates to enamine resins which are the reaction products of a) an acetoacetylated resin, and a C1-C20 alkyl amine or a mixture of C1-C20 alkyl amines. The acetoacetylated resin is the reaction product of a polyol having 4 or more hydroxyl groups; and at least one acetoacetate. The invention also relates to an acetoacetylated resin which is the reaction product of a polyol having 4 or more hydroxyl groups and at least one acetoacetate, where a portion of the hydroxyl groups of the polyol are replaced by acetoacetate groups and the remaining hydroxyl groups are replaced by a saturated monofunctional carboxylic acid ester, unsaturated monofunctional carboxylic acid ester, or a mixture thereof; as well as to enamine resins prepared from these acetoacetylated resins. The invention also relates to curable coating compositions containing such resins or a mixture of those resins, at least one metallic drier compound; and optionally one or more solvents.

Abstract: The present invention relates to methods of activate an isoform of protein kinase C (PKC) for the treatment of neurological diseases including Alzheimer's disease and stroke using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids. The present invention also relates to methods of reducing neurodegeneration using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids.

Abstract: The present invention relates to methods of activate an isoform of protein kinase C (PKC) for the treatment of neurological diseases including Alzheimer's disease and stroke using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids. The present invention also relates to methods of reducing neurodegeneration using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids.

Abstract: A mechanism for forming thin metallic skin enclosures from blanks. The apparatus includes a forming assembly including a plurality of die stations. The stations are stepped farther away from an axis in a direction of which blanks being processed are positioned at a plurality of die stations. Grippers spaced along the axis and away from the axis at distances substantially the same as are die stations are carried by the transfer assembly. An actuator is used to move the transfer assembly reciprocally in directions generally parallel to the axis between first and second axial positions. A ram is provided to move the transfer assembly between first and second stepped positions relative to the axis.

Abstract: The invention provides for the use of carbonic anhydrase activators; protein kinase C activators and FGF-18 to treat depressive disorders. The invention also relates to improved animal models and methods for screening and identifying compounds the treatment of depressive disorders.

Abstract: A combination wet kit includes a single mounting bracket supporting an end dump/return manifold and a walking floor/side dump/low boy manifold, as well as a support bracket for the hydraulic fluid filter. A three-way valve is positioned between the end dump/return manifold and a walking floor/side dump/low boy manifold. The manifold unit attached to the tractor without requiring holes in the tractor frame. The manifolds and the preassembled nature of the manifold assembly greatly simplify and reduce costs for installation of the combination wet kit.

Abstract: This invention relates to a highly efficient artificial low-density lipoprotein (LDL) carrier system for the targeted delivery therapeutic agents across the blood-brain barrier (BBB). In particular, this invention relates to artificial LDL particles comprised of three lipid elements: phosphatidyl choline, fatty-acyl-cholesterol esters, and at least one apolipoprotein. The present invention further relates to compositions, methods and kits comprising artificial LDL particles for targeting drugs to and across the BBB for the prevention and treatment of brain diseases.

Abstract: The present invention relates to methods of activate an isoform of protein kinase C (PKC) for the treatment of neurological diseases including Alzheimer's disease and stroke using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids. The present invention also relates to methods of reducing neurodegeneration using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids.

Abstract: A disengageable connector for interconnecting panels includes a longitudinally extending connector body. The connector body including a base and a projection extending from the base. The base includes a top surface and a bottom surface, and at least one footing member extending downwardly from the bottom surface of the base. The footing member is shaped and dimensioned to compress the upper surface of a resilient pad positioned beneath the connector and the panels. The connector is used in conjunction with an interlocking flooring system. The interlocking flooring system includes a plurality of flooring panels, each flooring panel including a plurality of edges. A first connecting member is provided for connecting adjacent flooring panels and a second connecting member is provided for connecting adjacent flooring panels. The first connecting member is the same as the connector described above and is different from the second connecting member.

Abstract: A chair mat includes a first decorative layer, the first decorative layer being composed of melamine-formaldehyde impregnated decorative sheet. The chair mat also includes a central core layer including a top first surface and a bottom second surface, the central core layer being composed of at least one resin impregnated sheet. The first decorative layer is coupled to the top first surface of the central core layer. The chair mat also includes a second decorative layer coupled to the bottom second surface of the central core layer, the second decorative layer being composed of a melamine-formaldehyde impregnated decorative sheet.